Collegium Pharmaceutical (COLL) Depreciation & Amortization - Total (2025 - 2026)
Collegium Pharmaceutical (COLL) posted Depreciation & Amortization - Total of $1.8 million for Q2 2026, up 291.36% on a QoQ basis from $463000.0 in Q1 2026, and up 59.65% year-over-year from $1.1 million in Q2 2025.
Powered by 
Analysis
Collegium Pharmaceutical (COLL) Depreciation & Amortization - Total (2025 - 2026) Analysis & Trends
Collegium Pharmaceutical has reported Depreciation & Amortization - Total for 2 years, with the latest figure at $1.8 million in Q2 2026.
- On a quarterly basis, Depreciation & Amortization - Total rose 59.65% year-over-year to $1.8 million in Q2 2026; TTM through Jun 2026 was $4.5 million, a N/A change from a year earlier, with the FY2025 full-year figure at $4.2 million, up 8.45% from the prior year.
- Depreciation & Amortization - Total was $1.8 million for Q2 2026 at Collegium Pharmaceutical, up from $463000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization - Total was $1.8 million in Q2 2026, with the low at $463000.0 in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | - |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | - |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | - |
| 10 | Collegium Pharmaceutical | 753.09 Mn | 603.77 Mn | 110.29 Mn | 1.81 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.81 Mn |
| Mar 31, 2026 | 463,000.00 |
| Jun 30, 2025 | 1.14 Mn |
| Mar 31, 2025 | 1.09 Mn |